• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Arrowhead Pharmaceuticals (ARWR)

Common Shares
Sell: $71.00|Buy: $72.13|Change: 4.34 (-5.77%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products andclinical candidates designed to target different cell types within the body.

Address

177 East Colorado Boulevard
Suite 700
Pasadena
CA
USA
91105

Telephone

+1 646 304-3400

Website

https://www.arrowheadpharma.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20272027-05-07T16:30:00
Arrowhead Pharmaceuticals Inc Second Quarter Earnings Results for 20272027-05-07T00:00:00
Arrowhead Pharmaceuticals Inc Annual General Meeting for 20262027-03-19T10:00:00
Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call for 20272027-02-05T16:30:00
Arrowhead Pharmaceuticals Inc First Quarter Earnings Results for 20272027-02-05T00:00:00
Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20262026-11-25T16:30:00
Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Results for 20262026-11-25T00:00:00
Arrowhead Pharmaceuticals Inc Annual Report for 20262026-11-25T00:00:00
Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20262026-08-07T16:30:00
Arrowhead Pharmaceuticals Inc Third Quarter Earnings Results for 20262026-08-07T00:00:00

Previous key dates

NameKey Date
2026 RBC Capital Markets Global Healthcare Conference2026-05-20T09:00:00
BofA Securities 2026 Healthcare Conference2026-05-13T10:00:00
Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20262026-05-07T16:30:00
Arrowhead Pharmaceuticals Inc Second Quarter Earnings Result for 20262026-05-07T00:00:00
Arrowhead Pharmaceuticals Inc Annual General Meeting for 20252026-03-19T10:00:00
Leerink 2026 Global Healthcare Conference2026-03-09T14:20:00
TD Cowen 46th Annual Health Care Conference2026-03-02T11:50:00
Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call for 20262026-02-05T16:30:00
Arrowhead Pharmaceuticals Inc First Quarter Earnings Results for 20262026-02-05T00:00:00
J.P. Morgan 2026 Healthcare Conference2026-01-12T10:30:00
Interim results of the Company's Phase 1/2a studies of ARO-INHBE and ARO-ALK7.2026-01-06T11:30:00
Company KOL Webinar2026-01-06T11:00:00
8th Annual Evercore Healthcare Conference2025-12-04T10:00:00
Piper Sandler 37th Annual Healthcare Conference2025-12-03T10:30:00
Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252025-11-25T16:30:00
Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Result for 20252025-11-25T00:00:00
Arrowhead Pharmaceuticals Inc Annual Report for 20252025-11-25T00:00:00
TD Cowen's Virtual Treatment Advancements in Obesity & Related Disorders2025-11-24T13:30:00
Jefferies Global Healthcare Conference 20252025-11-19T06:00:00
Arrowhead Pharmaceuticals Redemplo® (plozasiran) – FDA Approval Conference Call2025-11-18T13:30:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-10T11:30:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-09T10:30:00
Cantor Global Healthcare Conference 20252025-09-04T09:10:00
Citi's 2025 Biopharma Back to School Conference2025-09-03T13:00:00
Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-08-07T16:30:00
Arrowhead Pharmaceuticals Inc Third Quarter Earnings Results for 20252025-08-07T00:00:00
46th Annual Goldman Sachs Global Healthcare Conference2025-06-09T14:00:00
Jefferies Global Healthcare Conference2025-06-04T09:20:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.